Looking at the SNP's in Clinvar, for example http://www.ncbi.nlm.nih.gov/clinvar/variation/11/, I see that the SNP NM_000410.3(HFE):c.193A>T (p.Ser65Cys) (also known as rs1800730) corresponds to the disease hemochromatosis. Since we have 2 alleles, that means the genotype possibilities are AA, AT, or TT. From the ClinVar data, is it possible to see which genotype are associated with the disease? I assume that since we have a A to T mutation, then T must be the pathogenic allele. So, does this mean TT is worse than AT which is worse than AA?
Seqanswers Leaderboard Ad
Collapse
Announcement
Collapse
No announcement yet.
X
-
Originally posted by leontp587 View PostLooking at the SNP's in Clinvar, for example http://www.ncbi.nlm.nih.gov/clinvar/variation/11/, I see that the SNP NM_000410.3(HFE):c.193A>T (p.Ser65Cys) (also known as rs1800730) corresponds to the disease hemochromatosis. Since we have 2 alleles, that means the genotype possibilities are AA, AT, or TT. From the ClinVar data, is it possible to see which genotype are associated with the disease? I assume that since we have a A to T mutation, then T must be the pathogenic allele. So, does this mean TT is worse than AT which is worse than AA?
-
Hello,
whether AT or TT is needed to be pathogenic depends on the mode of inheritance. Is it dominant than it is enough if one allele has T, if it is recessive you need TT (or a second mutation in the gene on the other allele).
In clinvar you find under "Condition(s)" links to OMIM, where you can read about the inheritance.
fin swimmer
Comment
-
Comment
Latest Articles
Collapse
-
by seqadmin
During the COVID-19 pandemic, scientists observed that while some individuals experienced severe illness when infected with SARS-CoV-2, others were barely affected. These disparities left researchers and clinicians wondering what causes the wide variations in response to viral infections and what role genetics plays.
Jean-Laurent Casanova, M.D., Ph.D., Professor at Rockefeller University, is a leading expert in this crossover between genetics and infectious...-
Channel: Articles
09-09-2024, 10:59 AM -
-
by seqadmin
The first FDA-approved CRISPR-based therapy marked the transition of therapeutic gene editing from a dream to reality1. CRISPR technologies have streamlined gene editing, and CRISPR screens have become an important approach for identifying genes involved in disease processes2. This technique introduces targeted mutations across numerous genes, enabling large-scale identification of gene functions, interactions, and pathways3. Identifying the full range...-
Channel: Articles
08-27-2024, 04:44 AM -
ad_right_rmr
Collapse
News
Collapse
Topics | Statistics | Last Post | ||
---|---|---|---|---|
Started by seqadmin, 09-11-2024, 02:44 PM
|
0 responses
11 views
0 likes
|
Last Post
by seqadmin
09-11-2024, 02:44 PM
|
||
Started by seqadmin, 09-06-2024, 08:02 AM
|
0 responses
145 views
0 likes
|
Last Post
by seqadmin
09-06-2024, 08:02 AM
|
||
Started by seqadmin, 09-03-2024, 08:30 AM
|
0 responses
152 views
0 likes
|
Last Post
by seqadmin
09-03-2024, 08:30 AM
|
||
Started by seqadmin, 08-27-2024, 04:40 AM
|
0 responses
161 views
0 likes
|
Last Post
by seqadmin
08-27-2024, 04:40 AM
|
Comment